RePORT International Highlights

The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Notice of Funding Opportunity Announcement requires that at lease 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

Fogarty's new webpage 'NIH Support of International Research: Navigating NIH Public Resources' website page contains useful information for researchers. Alongside links to NIH Guide Notices and NIH extramural news resources, the page offers guidance on the newly published application and award structure for applications that request funding for international organizations (the PA-26-002 NIH Collaborative International Research Project--Parent PF5 Clinical Trial Optional).

Funding Opportunity Purpose: The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. This initiative encourages high risk high impact transformative studies that advance knowledge and strategies for HIV prevention, diagnosis, treatment and virus suppression in people who use substances and/or have a substance use disorder. Funding Opportunity Goal(s): To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS. Application due date: Multiple dates, see announcement.

Application due date: Multiple dates, see announcement

Application due date: Multiple dates, see announcement

Application due date: Multiple dates, see announcement

Funding Opportunity Purpose: The goal of this notice of funding opportunity (NOFO) is to address the opioid crisis and/or overdose events by supporting action-oriented research, accelerating the translation of addiction epidemiology, prevention, treatment services, and recovery research to practice. Proposed studies may target the individual, provider, organizational, community, or system level. This initiative prioritizes replicable and scalable approaches for accelerating the routine use of effective, evidence-based prevention, treatment and recovery interventions and services. The translation of research to practice and research relevant to chronic pain comorbid with substance use is also a priority. Research may deploy a variety of methods and approaches, including but not limited to identifying and characterizing malleable factors, developing and testing interventions and implementation strategies, deploying and testing collaborative data science approaches, and/or developing and testing approaches that integrate the collaboration of researchers and decision-makers at any levels (e.g., clinical-, health system-, public health- or policy-level). Funding Opportunity Goal(s): To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS. Application due date: Multiple dates, see announcement.

The purpose of this award is to support promising graduate students as they complete their doctoral research training and transition into mentored postdoctoral career development opportunities in research areas relevant to the missions of participating NIH Institutes and Centers. This Notice of Funding Opportunity (NOFO) does not allow fellowship candidates to propose to lead an independent clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor. NIH's mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. Please refer to the website for details

Funding Opportunity Purpose: The purpose of this notice of funding opportunity (NOFO) is to facilitate the entry of investigators into multiple high-priority areas of substance use research, including comorbidity with HIV. The Science Track Award for Research Transition (START) Program aims to provide investigators with the opportunity to gather preliminary data that will assist them in securing future research grants and advancing their scientific careers. Funding Opportunity Goal(s): To support basic, clinical, translational, epidemiological, or intervention science in the field of substance use. To develop new skillsets, knowledge, and/or approaches for the prevention, diagnosis, and treatment of substance use, misuse, addiction, drug overdose, and related health outcomes, including HIV/AIDS. Application due date: Multiple dates, see announcement.

The purpose of the NIH Research Conference Grant (R13) is to support high quality scientific conferences that are relevant to the NIH's mission and to the public health. A conference is defined as a symposium, seminar, workshop, or any other organized and formal meeting, whether conducted face-to-face or via the internet, where individuals assemble (or meet virtually) for the primary purpose to exchange technical information and views or explore or clarify a defined subject, problem, or area of knowledge, whether or not a published report results from such meeting. The NIH recognizes the value to members of the research community and all other interested parties in supporting such forums. Support of conferences is contingent on the fiscal and programmatic interests and priorities of the individual NIH Institutes and Centers

Open Date (Earliest Submission Date): April 07, 2025; Expiration Date: January 08, 2028 Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project. Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is five years.

Open Date (Earliest Submission Date): May 07, 2025; Expiration Date: January 08, 2028 Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project. Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is five years.

Open Date (Earliest Submission Date): May 07, 2025; Expiration Date: January 08, 2028 Award Budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 in direct costs may be requested in any single year. Award Project Period may not exceed 2 years.

DEADLINE FOR LETTER OF INTENT: 28 April 2026; 5 pm (ET) DEADLINE FOR APPLICATION:1 September 2026; 5 pm (ET) This PCORI Funding Announcement (PFA) invites applications for high impact patient-centered comparative clinical effectiveness research (CER) projects that will address critical decisions faced by patients, families, caregivers, clinicians, and the health and healthcare community and for which there is insufficient evidence. Investigators must propose an individual-level or cluster randomized controlled trial of significant scale and scope for this PFA. The proposed trials should address critical decisional dilemmas that require important new evidence about the comparative clinical effectiveness of available interventions. Proposed studies should compare interventions that already have robust evidence of efficacy and are in current use. If efficacy is not well established, then widespread use must be documented. Clinical interventions (such as medications, diagnostic tests, or procedures) and delivery system interventions (such as workforce, technologies and healthcare service delivery designs) are appropriate for these studies. Please refer to the website for the details.

The PIDS Foundation is pleased to offer annual fellowships and research awards to fellows and faculty. The goal of the PIDS award program is to increase the pool of highly trained pediatric infectious disease clinical scientists and to stimulate scholarly basic, translational, and clinical research in areas pertinent to Pediatric Infectious Diseases, including innovative research to improve or develop new vaccines and immunotherapeutics for children. Please refer to the websites for the details on various fellowships.

Boost offers comprehensive training opportunities for immunization professionals that are both adaptive and technical. Our adaptive trainings pair with a specific immunization topic (e.g., life course immunization) and focus on building, developing and deepening leadership skills for community organizing. Graduates of our advanced training develop the capacity to deliver their own training to the Boost Community or within their own communities. The Stop TB Partnership is a supporting partner.

The Searle Scholars Program makes grants to selected universities and research institutes to support the independent research of exceptional young faculty in the biomedical sciences and chemistry. Searle Scholars Award Grants are set at $450,000 for a three-year period with $150,000 payable each year. Participating institutions may nominate outstanding early-career scientists to apply for the program. Applications are accepted annually from June through September, only through an online application system. Please refer to the website for the details.

DEADLINE FOR SUBMISSION: 31 October 2026 The German Central Committee against (DZK e.V.) is looking for the best media work on the subject of tuberculosis. The prize, worth €2,500, recognizes contributions that make a significant contribution to understanding the disease and combating it. Journalistic works (print, TV, film, radio, online) and artistic projects in German or relevant to the German-speaking world are welcome. publications the years 2024 to 2026 can be submitted. The prerequisites for an award are current relevance and medical and factual accuracy of the presentation. The award ceremony will take place in March 2027 during the TB AKTUELL conference in Berlin.

Abstract, Travel Grant, and Challenging Case Submissions Now Open Deadline for Submissions: 21 September 2026 February 24 – 28, 2027 | Vancouver, BC, Canada The 2027 End TB Conference of the Union North American Region is looking forward to holding its 31st annual conference at the Sheraton Vancouver Wall Centre Hotel, 1000 Burrard St, Vancouver, BC, Canada, from February 24-27, 2027. We hope that you will join us in person to participate in our pre-conference postgraduate sessions and stay to attend our full conference. Please visit our website for ongoing conference program updates as we finalize our agenda over the next few months. We look forward to seeing to both new and familiar faces in support of the North American TB community.

The Union World Conference on Lung Health brings together researchers, practitioners, advocates, policymakers and communities from around the world to share knowledge, exchange ideas and accelerate progress in lung health. Rio de Janeiro, Brazil; 17–20 November 2026 Please refer to the website for registrations, program information and key dates